Maverick Therapeutics
Brisbane, US · Founded 2016 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
HP
Hans Peter GerberExecutive
Board
BG
DH
LE
CA
Christopher ArendtBoard director
LK
Lori KunkelBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$56M disclosed across 1 round · 2017
▶$56MraisedJan 2017 · 5 investors · BiotechnologyRule 506(b)
▶$56MraisedJan 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bard GeesamanDirector
- Dan HicklinDirector
- Luke EvninDirector
- Christopher ArendtDirector
- Lori KunkelDirector
- Hans Peter GerberExecutive Officer, Director
- Offering amount
- $56M
- Amount sold
- $56M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Maverick Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Maverick Therapeutics's investors?
- Maverick Therapeutics's investors include MPM BioImpact.
- How much funding has Maverick Therapeutics raised?
- Maverick Therapeutics has disclosed $56M raised across 1 round.
- Where is Maverick Therapeutics headquartered?
- Maverick Therapeutics is headquartered in Brisbane, US.